Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

In vitro antitumor activity of lactoferrin

April 15, 1997

Antineoplastic cryptophycin compounds

April 15, 1997

Immunogene therapy for cancer enters clinical trials

April 14, 1997

Novartis describes small-molecule signal transduction inhibitors

April 14, 1997

RPR cleared to market Taxotere in Malaysia and Hungary

April 11, 1997

Eisai prepares potent antitumor agents

April 11, 1997

TX-1877: new hypoxic cell radiation enhancer

April 11, 1997

MDR-reversing agents described by Nikken Chemicals

April 11, 1997

UCSF receives NIH funding for research into anticancer protease inhibitors

April 11, 1997

Farnesyltransferase inhibitors from Zeneca

April 10, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...